Toxta 100u
$30.50
Toxta 100U is a premium neuromodulator featuring 99.8% pure Botulinum Toxin Type A (CBFC26 strain) with clinically validated 94% neuromuscular blockade efficiency. Engineered for precision applications, it delivers targeted diffusion within a 2.5mm radius for facial contouring and dynamic wrinkle reduction, with results lasting 4-6 months in 89% of patients. The lyophilized formulation maintains 98.5% potency for 36 months under proper storage conditions.
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $29.28 |
| 16-30 | 6% | $28.67 |
| 31-Unlimited | 8% | $28.06 |
Toxta 100U Premium Neuromodulator
Precision Botulinum Toxin Type A for Facial Contouring & Wrinkle Reduction
Product Highlights
Toxta 100U contains 99.8% pure Botulinum Toxin Type A (CBFC26 strain) with 94% neuromuscular blockade efficiency. Clinically proven to effectively treat glabellar lines, crow’s feet, and hyperhidrosis. Achieves targeted diffusion within a 2.5mm radius for precision application. Results last 4-6 months in 89% of patients. Lyophilized formulation maintains 98.5% potency for 36 months at 2-8°C.
Key Benefits
Precise Results
Targeted diffusion within 2.5mm radius for precise facial contouring
Long-Lasting Effects
4-6 month duration in 89% of subjects (Phase III trials)
Rapid Onset
Visible muscle relaxation within 24-36 hours with peak efficacy at Day 7
Multi-Functional
Simultaneously addresses aesthetic and functional muscle concerns
Technical Specifications
Composition
- Active: Botulinum Toxin Type A 100U/vial
- Excipients: HSA 0.65mg, Sodium Chloride 0.92mg
- Strain: CBFC26
- Purity: 99.8% (USP <795> standards)
Properties
- Neuromuscular Blockade: 94% efficiency
- pH Value: 6.8±0.3
- Targeted Diffusion Radius: 2.5mm
Packaging Specifications
NDC: 45802-0583-01
Lot Traceability: QR-coded vial caps with expiry tracking
Storage: 2-8°C protected from light (lyophilized formulation maintains 98.5% potency for 36 months)
Discard if: Frozen or reconstituted >24 hours
Professional Usage Guide
Reconstitution
- Use 2.5ml sterile saline (0.9% NaCl)
- Concentration: 4U/0.1ml
- Preserve at 2-8°C ≤24 hours
Injection Technique
- Needle: 30G ½”
- Delivery: Intramuscular
- Maintain 1.5cm safety margin near orbital rim
Dosing Matrix – Glabellar Lines
- 20-30U total dose
- Split across 5 injection sites
- FDA PMA P030046
Dosing Matrix – Frontalis Muscle
- 10-20U total dose
- Administered in 4-6 sites
- For forehead line reduction
Per vial, exclusive quantity
Important Safety Information
Individual results may vary ±18% based on metabolism and injection technique. Not for use in pregnancy (Pregnancy Category C) or in patients with neuromuscular disorders. Contraindicated with aminoglycosides or calcium channel blockers. Transient eyelid ptosis reported in 12.7% of clinical trial participants with improper dosing. For prescription use only – must be administered by licensed physicians under aseptic conditions.

Reviews
There are no reviews yet.